Showing results (241-250 of 250) with videos related to
Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Endothelium : Journal of Endothelial Cell Research|July 15, 2006
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertensionGiuseppe Derosa, Angela D'Angelo, Leonardina Ciccarelli, et al.Frontiers in Pharmacology|January 30, 2023
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trialFrancesco Di Pierro, Amjad Khan, Somia Iqtadar, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 25, 2006
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepirideGiuseppe Derosa, Arrigo Francesco Giuseppe Cicero, Angela Dangelo, et al.Nutrients|January 11, 2025
Nutraceuticals and Supplements in Management of Prediabetes and DiabetesGiuseppe Derosa, Angela D'Angelo, Fabrizio Angelini, et al.Metabolism: Clinical and Experimental|December 18, 2009
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patientsGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.Journal of Cardiovascular Pharmacology|May 9, 2006
Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertensionGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 25, 2021
Proprotein convertase subtilisin/kexin type 9 inhibitors treatment in dyslipidemic patients: a real world prescriptionGiuseppe Derosa, Pamela Maffioli, Angela D'Angelo, et al.Journal of the Endocrine Society|December 28, 2020
PCSK-9 Inhibitors in a Real-World Setting and a Comparison Between Alirocumab and Evolocumab in Heterozygous FH PatientsJosé Juan Ceballos-Macías, Carolina Lara-Sánchez, Jorge Flores-Real, et al.European Journal of Preventive Cardiology|August 12, 2025
Cardiovascular risk factors management in older adults: a clinical consensus statement from the European Association of Preventive Cardiology of the ESC and the ESC Council for Cardiology PracticeRoberto F E Pedretti, Riccardo Asteggiano, Andreas B Gevaert, et al.International Journal of General Medicine|June 17, 2021
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label StudyFrancesco Di Pierro, Giuseppe Derosa, Pamela Maffioli, et al.Pageof 25